At Coalescence BioPharma, we provide science-driven support for innovative therapeutic programs, helping clients navigate U.S. clinical development, cross-border licensing, strategic positioning, and global partnership opportunities.
U.S. Clinical Development Strategy
- Program readiness assessment and U.S. development pathway planning
- Clinical development strategy, study design, and regulatory considerations
- Coordination with qualified CROs, clinical investigators, and specialized advisors
Cross-Border Licensing & Partnering
- Global opportunity sourcing aligned with clients' strategic priorities
- Licensing-in, licensing-out, and co-development support
- Partner identification, engagement, and transaction coordination
Scientific Evaluation & BD Advisory
- Scientific, clinical, and competitive assessment of therapeutic assets
- Product differentiation and global development positioning
- Non-confidential partnering materials and scientific communication support
